We are live on ! Find out more
SG

StepStone Group Portfolio holdings

AUM $207M
1-Year Est. Return 12.33%
This Fund
S&P 500
This Quarter Est. Return
-14.95%
1 Year Est. Return
-12.33%
3 Year Est. Return
+92.06%
5 Year Est. Return
+17.44%
10 Year Est. Return
+217.33%
AUM
$703M
AUM Growth
-$232M
Cap. Flow
-$102M
Cap. Flow %
-14.53%
Top 10 Hldgs %
91.88%
Holding
36
New
9
Increased
3
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
TRDA icon
Entrada Therapeutics
TRDA
+$1.6M
2
FRGE
Forge Global Holdings
FRGE
+$1.04M
3
VCSA
Vacasa, Inc. Class A Common Stock
VCSA
+$676K
4
PCOR icon
Procore
PCOR
+$426K
5
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$186K

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$100M
2
PL icon
Planet Labs
PL
+$3.6M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$2.03M
4
TXG icon
10x Genomics
TXG
+$153K
5
WMS icon
Advanced Drainage Systems
WMS
+$122K

Sector Composition

Rank Sector Weight
1 Financials 43%
2 Technology 29.67%
3 Healthcare 14.5%
4 Industrials 8.51%
5 Communication Services 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNB
1
DELISTED
Dun & Bradstreet
DNB
$273M 38.84%
22,042,226
– –
USER
2
DELISTED
UserTesting, Inc.
USER
$97.5M 13.86%
24,868,471
– –
WKME
3
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$88.1M 12.53%
10,366,855
– –
RKLB icon
4
Rocket Lab Corp
RKLB
$42.1B
$50M 7.1%
12,273,414
-20,147
-0.2% -$99.4K
NEUE
5
DELISTED
NeueHealth
NEUE
$43.8M 6.22%
521,066
– –
PATH icon
6
UiPath
PATH
$6.23B
$22.5M 3.2%
1,786,527
– –
ML
7
DELISTED
MoneyLion Inc.
ML
$21.7M 3.09%
813,661
– –
NGM
8
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$20.6M 2.93%
1,573,357
– –
RBLX icon
9
Roblox
RBLX
$38.7B
$16.8M 2.39%
469,052
+881
+0.2% +$36.4K
TRDA icon
10
Entrada Therapeutics
TRDA
$267M
$12M 1.71%
761,277
+126,318
+20% +$1.6M
HLVX
11
DELISTED
HilleVax
HLVX
$11.6M 1.64%
676,567
– –
VCSA
12
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$9.64M 1.37%
157,020
+9,759
+7% +$676K
ROVR
13
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$9.52M 1.35%
2,849,340
– –
IMGO
14
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$7.87M 1.12%
522,987
– –
DOMA
15
DELISTED
Doma Holdings, Inc.
DOMA
$6.55M 0.93%
595,179
– –
PHAT icon
16
Phathom Pharmaceuticals
PHAT
$875M
$4.68M 0.67%
422,085
– –
GROV icon
17
Grove Collaborative
GROV
$45.8M
$3.91M 0.56%
348,813
– –
TNYA icon
18
Tenaya Therapeutics
TNYA
$182M
$1.34M 0.19%
462,163
– –
TWAV
19
TaoWeave Inc
TWAV
$4.08M
$554K 0.08%
6,154
– –
FRGE
20
DELISTED
Forge Global Holdings
FRGE
$396K 0.06%
+15,080
New +$1.04M
PCOR icon
21
Procore
PCOR
$6.81B
$392K 0.06%
+7,930
New +$426K
XMTR icon
22
Xometry
XMTR
$5.33B
$227K 0.03%
3,990
-2,144,755
-100% -$100M
KDNY
23
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$182K 0.03%
+9,277
New +$186K
BASE
24
DELISTED
Couchbase
BASE
$68K 0.01%
+4,773
New +$77.2K
ACVA icon
25
ACV Auctions
ACVA
$1.33B
$63K 0.01%
+8,816
New +$70K
1
2

Similar funds

SNBOSD
Security National Bank of So Dak Sioux City, Iowa $207M AUM 21.03% 1-Year Est. Return
MPCG
Matrix Private Capital Group New York $207M AUM 16.87% 1-Year Est. Return
BWM
Birchcreek Wealth Management Miami Township, Ohio $208M AUM 18.75% 1-Year Est. Return
HCA
Hyperion Capital Advisors New York $208M AUM 10.31% 1-Year Est. Return
KIC
Kensington Investment Counsel Long Beach, California $208M AUM 11.99% 1-Year Est. Return
CC
CIBRA Capital London, United Kingdom $207M AUM
JWM
Johnson Wealth Management Grand Forks, North Dakota $207M AUM
PM
Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return

StepStone Group's Q3 2022 Portfolio in Review

As of Q3 2022, StepStone Group held 36 positions worth $703M, down 25% from $935M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

StepStone Group withdrew a net $102M in Q3 2022, closing 6 positions and reducing 2 holdings. Its most notable exit was Planet Labs, an estimated $3.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, StepStone Group opened a new position in Forge Global Holdings worth $396K.

  • StepStone Group's largest Q3 2022 buy was Forge Global Holdings: 15,080 shares worth $396K.
  • StepStone Group added most to Entrada Therapeutics in Q3 2022, an estimated $1.6M increase.
  • StepStone Group's biggest Q3 2022 reduction was Xometry, cutting an estimated $100M.
  • StepStone Group fully exited Planet Labs in Q3 2022, selling an estimated $3.6M.
  • StepStone Group's ten largest holdings make up 92% of its $703M portfolio in Q3 2022.
  • StepStone Group opened 9 new positions and closed 6 in Q3 2022.
  • StepStone Group's portfolio value fell 25% quarter-over-quarter to $703M.

Based on StepStone Group's 13F filing for Q3 2022, filed 14 Nov 2022.